Nkarta, Inc. Share Price
NKTX$0.00
+0.00 (0.00%) Nkarta, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Nkarta, Inc. Share Price Chart
$0.00
Please wait...
About Nkarta, Inc.
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. It has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Nkarta, Inc. Historical Data
| Day | Open | Close | Change % |
|---|
FAQs on Nkarta, Inc. Share Price
Can I buy Nkarta, Inc. shares in India?
Yes. You can buy Nkarta, Inc. in India by opening an international trading account.
What is the share price of Nkarta, Inc.?
As on 01 Mar '26, the share price of Nkarta, Inc. NKTX is $0.00. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.
What is the 5 year returns of Nkarta, Inc.?
The 5 year returns of Nkarta, Inc. is as on 01 Mar '26.
What are the high & low stock price of Nkarta, Inc. today?
Nkarta, Inc. stock price hit a high of $0.00 and low of $0.00 as on 01 Mar '26.
What is the 52-week high and low of Nkarta, Inc. stock?
The 52-week high of Nkarta, Inc. stock is $0.00, while the 52-week low is $0.00 as on 01 Mar '26.